Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
20.9M
-
Shares change
-
-142K
-
Total reported value, excl. options
-
$93.8M
-
Value change
-
-$1.17M
-
Put/Call ratio
-
0.71
-
Number of buys
-
22
-
Number of sells
-
-32
-
Price
-
$4.49
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2022
69 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q3 2022.
Apyx Medical Corp - Common Stock (APYX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.9M shares
of 35M outstanding shares and own 59.72% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.4M shares), COWEN AND COMPANY, LLC (2.85M shares), Archon Capital Management LLC (2.69M shares), PURA VIDA INVESTMENTS, LLC (1.51M shares), VANGUARD GROUP INC (1.41M shares), Kent Lake Capital LLC (1.05M shares), Invenire Partners, LP (946K shares), UBS Group AG (889K shares), ROYCE & ASSOCIATES LP (884K shares), and HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.